Filing Details
- Accession Number:
- 0001181431-13-004637
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-01-24 17:12:46
- Reporting Period:
- 2013-01-23
- Filing Date:
- 2013-01-24
- Accepted Time:
- 2013-01-24 17:12:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1338042 | Aegerion Pharmaceuticals Inc. | AEGR | Pharmaceutical Preparations (2834) | 202960116 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1213040 | J. Martha Carter | C/O Aegerion Pharmaceuticals, Inc. 101 Main Street, Suite 1850 Cambridge MA 02142 | Chief Regulatory Officer & Svp | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-01-23 | 500 | $27.81 | 1,500 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
